FYERS
iSERA Lifesciences 143.90
+0.00 (+0.00%)

iSERA Lifesciences Share Price

143.90+0.00 (+0.00%)
+1466.98% past 1 Year

Corporate filings & documents

Announcements

Disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations 2015 - Continual Disclosure consequent to Preferential Allotment of Equity Shares on a Share Swap Basis
4 days ago
Disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations 2015 - Continual Disclosure consequent to Preferential Allotment of Equity Shares on a Share Swap Basis
4 days ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Archana Lonkar
5 days ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Nandkumar Kadam
5 days ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhairyasheel Yadav
6 days ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhairyasheel Yadav
6 days ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sumeet Dhanraj Garad
6 days ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sumeet Dhanraj Garad
6 days ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pratap Dadasaheb Deshmukh & PACs
6 days ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pratap Dadasaheb Deshmukh & PACs
6 days ago
The Board of Directors of the Company at its meeting held today i.e. October 01 2026 has approved the allotment of 1 61 82 800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) fully paid-up equity shares of face value of Rs. 10/- (Rupees Ten only) each at an issue price of Rs. 48.20/- (Rupees Forty-Eight and Paise Twenty only) per share [including a share premium of Rs. 38.20/- (Rupees Thirty-Eight and Paise Twenty only) per share] on a preferential basis by way of Share Swap at a ratio of 1:1 (i.e. one equity share of the Company for every one equity share of iSERA Biological Limited held by the allottee) to the following allottees belonging to the Promoter and Non-Promoter categories.
1 week ago
The Board of Directors of the Company at its meeting held today i.e. October 01 2026 has approved the allotment of 1 61 82 800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) fully paid-up equity shares of face value of Rs. 10/- (Rupees Ten only) each at an issue price of Rs. 48.20/- (Rupees Forty-Eight and Paise Twenty only) per share [including a share premium of Rs. 38.20/- (Rupees Thirty-Eight and Paise Twenty only) per share] on a preferential basis by way of Share Swap at a ratio of 1:1 (i.e. one equity share of the Company for every one equity share of iSERA Biological Limited held by the allottee) to the following allottees belonging to the Promoter and Non-Promoter categories.
1 week ago
The Board of Directors of the Company at its meeting held today i.e. October 01 2026 has approved the allotment of 1 61 82 800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) fully paid-up equity shares of face value of Rs. 10/- (Rupees Ten only) each at an issue price of Rs. 48.20/- (Rupees Forty-Eight and Paise Twenty only) per share [including a share premium of Rs. 38.20/- (Rupees Thirty-Eight and Paise Twenty only) per share] on a preferential basis by way of Share Swap at a ratio of 1:1 (i.e. one equity share of the Company for every one equity share of iSERA Biological Limited held by the allottee) to the following allottees belonging to the Promoter and Non-Promoter categories.
1 week ago
The Board of Directors of the Company at its meeting held today i.e. October 01 2026 has approved the allotment of 1 61 82 800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) fully paid-up equity shares of face value of Rs. 10/- (Rupees Ten only) each at an issue price of Rs. 48.20/- (Rupees Forty-Eight and Paise Twenty only) per share [including a share premium of Rs. 38.20/- (Rupees Thirty-Eight and Paise Twenty only) per share] on a preferential basis by way of Share Swap at a ratio of 1:1 (i.e. one equity share of the Company for every one equity share of iSERA Biological Limited held by the allottee) to the following allottees belonging to the Promoter and Non-Promoter categories.
1 week ago
We are hereby submitting the Consolidated Scrutinizers Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known as Covidh Technologies Limited held through Video Conferencing (VC)/Other Audio Visual Means (OAVM) on Tuesday 29th September 2026 at 3:00 P.M.
1 week ago
We are hereby submitting the Consolidated Scrutinizers Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known as Covidh Technologies Limited held through Video Conferencing (VC)/Other Audio Visual Means (OAVM) on Tuesday 29th September 2026 at 3:00 P.M.
1 week ago
We hereby submit the proceeding of the 34th AGM
1 week ago
We hereby submit the proceeding of the 34th AGM
1 week ago
We hereby submit the Closure of Trading Window for iSEAR LifeSciences Limited (Formerly Known as Covidh Technologies Limited
2 weeks ago
We hereby submit the Closure of Trading Window for iSEAR LifeSciences Limited (Formerly Known as Covidh Technologies Limited
2 weeks ago
We hereby submit the copy of Newspaper Publication of Public Notice regarding 34th Annual General Meeting (AGM) of the Company scheduled to be held on Tuesday September 29 2026 at 3:00 P.M. (IST) through VC/ OAVM .
1 month ago
We hereby submit the copy of Newspaper Publication of Public Notice regarding 34th Annual General Meeting (AGM) of the Company scheduled to be held on Tuesday September 29 2026 at 3:00 P.M. (IST) through VC/ OAVM .
1 month ago
we hereby submit Annual Report of Annual General Meeting of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the financial year 2025-26
1 month ago
we hereby submit Annual Report of Annual General Meeting of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the financial year 2025-26
1 month ago
Notice of 34th Annual General Meeting (AGM) of the Company is scheduled to be held on Tuesday September 29 2026 at 3:00 P.M. (IST) through video conference (VC)/ other audio visual means (OAVM) in compliance with the applicable provisions of the Companies Act 2013 and rules made thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) and relevant circulars issued by MCA and SEBI.
1 month ago
Notice of 34th Annual General Meeting (AGM) of the Company is scheduled to be held on Tuesday September 29 2026 at 3:00 P.M. (IST) through video conference (VC)/ other audio visual means (OAVM) in compliance with the applicable provisions of the Companies Act 2013 and rules made thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) and relevant circulars issued by MCA and SEBI.
1 month ago
iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) has filed with the exchange copy of newspaper publication.
1 month ago
iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) has filed with the exchange copy of newspaper publication.
1 month ago
We hereby informed that Board of Directors of the Company at its meeting held on Tuesday the 01st September 2026 discuss the agenda attached herewith.
1 month ago
We hereby informed that Board of Directors of the Company at its meeting held on Tuesday the 01st September 2026 discuss the agenda attached herewith.
1 month ago
We hereby submit the monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended June 30 2026.
1 month ago
We are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30 2026.
2 months ago
We are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30 2026.
2 months ago
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Friday the 07th day of August 2026 at the Registered Office of the Company which commenced at 02:00 P.M.and concluded at 02:30 P.M. considered and approved inter alia to approve the Un-Audited Financial Results of the Company for the quarter ended June 30 2026.
2 months ago
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Friday the 07th day of August 2026 at the Registered Office of the Company which commenced at 02:00 P.M.and concluded at 02:30 P.M. considered and approved inter alia to approve the Un-Audited Financial Results of the Company for the quarter ended June 30 2026.
2 months ago
Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended on June 30 2026
2 months ago
Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended on June 30 2026
2 months ago
We are hereby submitting the Certificate issued by Share Transfer Agent of the Company confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on 30th June 2026.
3 months ago
We are hereby submitting the Certificate issued by Share Transfer Agent of the Company confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on 30th June 2026.
3 months ago
Scrutinizers Report and Voting Results of the Re-opened Postal Ballot (Remote E-Voting) conducted pursuant to the Corrigendum to the Postal Ballot Notice dated June 26 2026.
3 months ago
Scrutinizers Report and Voting Results of the Re-opened Postal Ballot (Remote E-Voting) conducted pursuant to the Corrigendum to the Postal Ballot Notice dated June 26 2026.
3 months ago
Submission of Newspaper Advertisement of Corrigendum to the Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 months ago
Submission of Newspaper Advertisement of Corrigendum to the Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 months ago
We wish to inform you that iSERA Lifesciences Limited (Formerly known as Covidh TechnologiesLimited) has issued a Corrigendum to the Notice of Postal Ballot dated April 21 2026 videCorrigendum dated June 26 2026 in connection with the proposed preferential issue of equity shares forconsideration other than cash (Share Swap). The said Corrigendum has been dispatched to all Members ofthe Company as on the cut-off date i.e. Friday April 17 2026 on June 26 2026.A copy of the Corrigendum is enclosed herewith for your kind perusal and records.Kindly take the above on record.
3 months ago
We wish to inform you that iSERA Lifesciences Limited (Formerly known as Covidh TechnologiesLimited) has issued a Corrigendum to the Notice of Postal Ballot dated April 21 2026 videCorrigendum dated June 26 2026 in connection with the proposed preferential issue of equity shares forconsideration other than cash (Share Swap). The said Corrigendum has been dispatched to all Members ofthe Company as on the cut-off date i.e. Friday April 17 2026 on June 26 2026.A copy of the Corrigendum is enclosed herewith for your kind perusal and records.Kindly take the above on record.
3 months ago
We are hereby submitting the Closure of Trading Window for the Quarter June 30 2026.
3 months ago
We are hereby submitting the Closure of Trading Window for the Quarter June 30 2026.
3 months ago
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of iSERA Lifesciences Limited (formerly known as "Covidh Technologies Limited") was held on Wednesday June 11 2026. The following businesses were transacted at the aforesaid Board Meeting:
4 months ago
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of iSERA Lifesciences Limited (formerly known as "Covidh Technologies Limited") was held on Wednesday June 11 2026. The following businesses were transacted at the aforesaid Board Meeting:
4 months ago
We hereby submit the Newspaper Advertisement for the financial result for the year and quarter ended March 31 2026
4 months ago

Annual reports

FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

iSERA Lifesciences Ltd Share Price Today

The iSERA Lifesciences Ltd share price today is ₹143.9. During the trading session, the iSERA Lifesciences Ltd share price opened at ₹0 and recorded an intraday high of ₹0 and a low of ₹0. Last closing price was ₹143.9. Over the past 52 weeks, the iSERA Lifesciences Ltd share price has ranged between ₹7.99 and ₹151.05. The current iSERA Lifesciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.